Durham, NC
Tune Therapeutics strives to develop paradigm-changing cell and gene therapies that leverage epigenetic programming for the treatment of devastating diseases.
tunetx.comThese are collections Tune Therapeutics is a part of. Click on the collection name to view similar companies.
Series B
$175,000,000
Series A
$40,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Tune Therapeutics.